China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on personalized nostalgic intervention of subthreshold depression in the elde... Read More
China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical research on molecular probes targeting chemokine receptor 4 (CXCR4)'. The fol... Read More
China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study of the Efficacy and Safety of Maribavir for Cytomegalovirus (CMV) Infection Foll... Read More
China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Comparison of Four Laboratory Tests for Early Detection of Clonorchis sinensis Infec... Read More
China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Diabetic Foot Risk Evaluation System with Intelligent Guidance and Hierarchical Tracki... Read More
China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Breaking the Climate–Procrastination Vicious Cycle: Effects of Acceptance and Commitme... Read More
China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Survey on Care Knowledge Needs of Patients After Facial Cosmetic Suturing'. The follow... Read More
China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Significance of TP53 Mutations in Chronic Lymphocytic Leukemia/Small Lymphocy... Read More
China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Validation of a Depression Treatment Response Prediction Model in Adolescents and Youn... Read More
China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-Center, Prospective, Single-Arm Clinical Study of Serplulimab Combined with C... Read More